Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06456463 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 76 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Stemline Therapeutics, Inc. |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of March 2, 2026: Clinical trial NCT06456463 is currently recruiting participants. This clinical trial study for acute myeloid leukemia is actively seeking new participants at 25 locations across the United States. The study is sponsored by Stemline Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06456463 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06456463 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.